Effect of CLDN1 mAb on primary patient derived liver organoids. Effect of CLDN1 mAb on primary patient derived liver organoids
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Organoids were established from non-tumorous cirrhotic liver tissue and treated with CLDN1 mAb or Control mAb for 4 days. Organoids were harvested and mRNA was extracted. RNAsequencing was performed for comparative gene expression profiling. Overall design: Transcriptomic profiling analysis of primary liver organoids treated with CLDN1 mAb or Control mAb.
创建时间：
2022-06-21
